PRICE T ROWE ASSOCIATES INC /MD/
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$214,440,338
+$103,893,246 QoQ
Shares Held
8,861,171
+31.9% QoQ
Ownership
10.4%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 193 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. GLUE ranks #24 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in GLUE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,443,024 | 8,861,282 | Shares | Sole | 2026-07-08 | |
| 2026-06-30 | $214,440,338 | 8,861,171 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $110,547,092 | 6,720,188 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $80,264,414 | 5,118,904 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,360,613 | 4,637,060 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,528,717 | 6,325,658 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $30,828,790 | 6,644,136 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $49,389,460 | 7,116,637 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,986,046 | 6,601,141 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,356,174 | 5,977,587 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $35,932,347 | 5,096,787 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,916,123 | 4,940,907 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $18,539,919 | 3,870,547 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,691,010 | 3,896,498 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $28,772,317 | 3,693,494 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,030,902 | 3,683,430 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $30,746,862 | 3,763,386 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $50,759,135 | 5,249,135 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $75,019,940 | 5,350,923 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $84,680,085 | 4,146,919 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $70,113,689 | 3,146,934 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $62,144,745 | 2,737,654 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||